E4512 A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Primary Objective
This is a double-blind clinical trial of Crizotinib(investigational) that will be administered orally.
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital
Principal Investigator
Tejas Patil, MD
Study ID
Protocol Number: 14-1915
More information available at ClinicalTrials.gov: NCT02201992
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers